Showing: 1 - 2 of 2 RESULTS

FDA posts vaccine guidelines blocked by White House

Nurse Kathe Olmstead prepares a shot that is part of a possible COVID-19 vaccine, developed by the National Institutes of Health and Moderna Inc., in Binghamton, N.Y.

Hans Pennink | AP

The Food and Drug Administration laid out updated safety standards Tuesday for makers of Covid-19 vaccines after the White House blocked their formal release, the latest political tug-of-war between the Trump administration and the government’s public health scientists.

In briefing documents posted on its website, the FDA said vaccine makers should follow trial participants for at least two months to rule out safety issues before seeking emergency approval. That requirement would almost certainly preclude the introduction of a vaccine before Nov. 3.

President Donald Trump has repeatedly insisted a vaccine could be authorized before Election Day, even though top government scientists working on the effort have said that timeline is very unlikely. On Monday Trump said vaccines are coming “momentarily,” in a video recorded after he returned to the White House. 

Former FDA officials have warned that public perception that a vaccine was being rushed out for political reasons could derail efforts to vaccinate millions of Americans.

A senior administration official confirmed to the AP on Monday that the White House had blocked FDA’s plans to formally publish the safety guidelines based on the 2-month data requirement, arguing there was “no clinical or medical reason” for it.

But the FDA tucked the information into a memo posted ahead of an Oct. 22 meeting of its outside vaccine advisory panel. The group of non-governmental experts is scheduled to discuss general standards for coronavirus vaccines, part of FDA’s effort to publicize its process and rationale for vaccine reviews. While information prepared for such panels does not carry the weight of a formal FDA guidance document, the release of the information makes clear the FDA plans to impose the safety standards for any vaccine seeking an expedited path to market. 

To meet the FDA’s threshold, companies would need to submit two months of follow-up from half of their trial participants after they receive their last vaccine dose to show there are no major side effects or health problems. Because vaccines are normally given to otherwise healthy people the FDA requires strict evidence of their safety.

The requirements are aimed at companies seeking rapid approval through the FDA’s emergency authorization pathway. That accelerated process, reserved for health emergencies, allows medical products onto the market based on a lower bar than traditional FDA approval. 

Initial doses of vaccines for emergency use would likely be reserved for medical workers and people with health conditions that make them particularly vulnerable to coronavirus. Full FDA approval for the general population will require significantly more data and is not expected until mid-2021.

An FDA spokeswoman said Tuesday the vaccine guidelines are still “under review” but added that “the FDA has already communicated with individual manufacturers about its expectations.”

The White House’s attempt to block the information’s release follows a string of instances in which the Trump administration has

Harvard Psychiatric Leader Appointed to Posts at Baylor College of Medicine and Menninger Clinic

HOUSTON, Sept. 28, 2020 /PRNewswire/ — Baylor College of Medicine and The Menninger Clinic jointly announce the hiring of Robert J. Boland, M.D., as vice chairman of the Menninger Department of Psychiatry and Behavioral Sciences at Baylor College of Medicine and chief of staff at The Menninger Clinic. Boland joins the organizations on January 4, 2021, after transitioning from Harvard Medical School and Brigham and Women’s Hospital.

Boland is currently vice chair of education and director of the psychiatry residency program at Brigham and Women’s Hospital. He is also an associate professor of psychiatry at Harvard Medical School and is board certified in psychiatry with expertise in medical education, psychosomatic medicine and geriatric psychiatry. He is an alumnus of Georgetown University where he earned his undergraduate and medical degrees.

Prior to joining Brigham and Women’s Hospital five years ago, Boland had an 18-year tenure at the Alpert School of Medicine at Brown University, Providence, RI. He developed special interest in depression resulting from medical illness and, with Brown and the Centers for Disease Control, he examined the influence of depression on the course of HIV in women.  Currently, he’s an associate editor of Journal of Technology in Behavioral Science.

“Dr. Boland brings exceptional leadership experience and skills to The Menninger Clinic and to Baylor College of Medicine. His focus on innovation and the application of technology in our field of medicine is important to patients of the Texas Medical Center,” says Wayne Goodman, M.D., Chair and the D.C. and Irene Ellwood Chair in Psychiatry, Baylor College of Medicine Department of Psychiatry and Behavioral Science.

As one of Baylor’s teaching hospitals for psychiatrists and psychologists, The Menninger Clinic values Boland’s mentoring of early-career psychiatrists and other mental health clinicians. In addition, His work in geriatric psychiatry and consultation-liaison psychiatry required the ability to treat complex patients, which Menninger has specialized in treating for 95 years.

“Dr. Boland is an innovator in the way patient care is delivered to meet the needs of communities today,” said Armando E. Colombo, president and CEO of The Menninger Clinic. “We share a common belief about the opportunity of psychiatry to improve the productivity and health of individuals, families and communities.”

A nationally ranked hospital, The Menninger Clinic serves Houston and Texas and is also a trusted assessment and treatment provider for people across the country.

Contact:  Nancy Trowbridg
C: 713-806-5061
ntrowbridge@menninger.edu

Cision
Cision

View original content to download multimedia:http://www.prnewswire.com/news-releases/harvard-psychiatric-leader-appointed-to-posts-at-baylor-college-of-medicine-and-menninger-clinic-301139227.html

SOURCE The Menninger Clinic

Source Article